Heart Failure With Preserved Ejection Fraction: Will Cardiac Magnetic Imaging Impact on Diagnosis, Treatment, and Outcomes?: Explaining the Need for Advanced Imaging to Clinical Stakeholders.
| Autor: | Moreyra C; From the Cardiology Department, Sanatorium Allende, Córdoba, Argentina., Moreyra E Jr; From the Cardiology Department, Sanatorium Allende, Córdoba, Argentina., Rozich JD; Mcleod Health Clarendon, Manning, SC. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | Cardiology in review [Cardiol Rev] 2024 Jul-Aug 01; Vol. 32 (4), pp. 371-377. Date of Electronic Publication: 2022 Dec 27. |
| DOI: | 10.1097/CRD.0000000000000494 |
| Abstrakt: | Clinicians frequently equate symptoms of volume overload to heart failure (HF) but such generalization may preclude diagnostic or etiologic precision essential to optimizing outcomes. HF itself must be specified as the disparate types of cardiac pathology have been traditionally surmised by examination of left ventricular (LV) ejection fraction (EF) as either HF with preserved LVEF (HFpEF-LVEF >50%) or reduced LVEF of (HFrEF-LVEF <40%). More recent data support a third, potentially transitional HF subtype, but therapy, assessment, and prognosis have been historically dictated within the corresponding LV metrics determined by echocardiography. The present effort asks whether this historically dominant role of echocardiography is now shifting slightly, becoming instead a shared if not complimentary test. Will there be a gradual increasing profile for cardiac magnetic resonance as the attempt to further refine our understanding, diagnostic accuracy, and outcomes for HFpEF is attempted? Competing Interests: Disclosure: The authors declare no conflict of interest. (Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved.) |
| Databáze: | MEDLINE |
| Externí odkaz: |
|